Atıf Formatları
A National, Multicenter, Secondary Data Use Study Evaluating Efficacy and Retension of First-Line Biologic Treatment with Tocilizumab in Patients with Rheumatoid Arthritis in Real-Life Setting from TURKBIO Registry
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. YAZICI Et Al. , "A National, Multicenter, Secondary Data Use Study Evaluating Efficacy and Retension of First-Line Biologic Treatment with Tocilizumab in Patients with Rheumatoid Arthritis in Real-Life Setting from TURKBIO Registry," Annual European Congress of Rheumatology, Paris, France , vol.2928, Paris, France, pp.1152-1153, 2021

YAZICI, A. Et Al. 2021. A National, Multicenter, Secondary Data Use Study Evaluating Efficacy and Retension of First-Line Biologic Treatment with Tocilizumab in Patients with Rheumatoid Arthritis in Real-Life Setting from TURKBIO Registry. Annual European Congress of Rheumatology, Paris, France , (Paris, France), 1152-1153.

YAZICI, A., ÖZDEMİR IŞIK, Ö., DALKILIÇ, H. E., KOCA, S. S., PEHLİVAN, Y., ŞENEL, S., ... İNANÇ, G. N.(2021). A National, Multicenter, Secondary Data Use Study Evaluating Efficacy and Retension of First-Line Biologic Treatment with Tocilizumab in Patients with Rheumatoid Arthritis in Real-Life Setting from TURKBIO Registry . Annual European Congress of Rheumatology, Paris, France (pp.1152-1153). Paris, France

YAZICI, AYTEN Et Al. "A National, Multicenter, Secondary Data Use Study Evaluating Efficacy and Retension of First-Line Biologic Treatment with Tocilizumab in Patients with Rheumatoid Arthritis in Real-Life Setting from TURKBIO Registry," Annual European Congress of Rheumatology, Paris, France, Paris, France, 2021

YAZICI, AYTEN Et Al. "A National, Multicenter, Secondary Data Use Study Evaluating Efficacy and Retension of First-Line Biologic Treatment with Tocilizumab in Patients with Rheumatoid Arthritis in Real-Life Setting from TURKBIO Registry." Annual European Congress of Rheumatology, Paris, France , Paris, France, pp.1152-1153, 2021

YAZICI, A. Et Al. (2021) . "A National, Multicenter, Secondary Data Use Study Evaluating Efficacy and Retension of First-Line Biologic Treatment with Tocilizumab in Patients with Rheumatoid Arthritis in Real-Life Setting from TURKBIO Registry." Annual European Congress of Rheumatology, Paris, France , Paris, France, pp.1152-1153.

@conferencepaper{conferencepaper, author={AYTEN YAZICI Et Al. }, title={A National, Multicenter, Secondary Data Use Study Evaluating Efficacy and Retension of First-Line Biologic Treatment with Tocilizumab in Patients with Rheumatoid Arthritis in Real-Life Setting from TURKBIO Registry}, congress name={Annual European Congress of Rheumatology, Paris, France}, city={Paris}, country={France}, year={2021}, pages={1152-1153} }